VENUS REMEDIES LTD.

NSE : VENUSREMBSE : 526953ISIN CODE : INE411B01019Industry : Pharmaceuticals & DrugsHouse : Private

BSE164.153.45 (+2.15 %)

PREV CLOSE ( ) 160.70

OPEN PRICE ( ) 162.55

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2707

TODAY'S LOW / HIGH ( )161.90 165.20

52 WK LOW / HIGH ( )145 378.9

NSE164.053.85 (+2.4 %)

PREV CLOSE( ) 160.20

OPEN PRICE ( ) 157.95

BID PRICE (QTY) 164.05 (1)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 27971

TODAY'S LOW / HIGH( ) 157.95 167.25

52 WK LOW / HIGH ( )145.8 379.5

More From Company Profile

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1989

Management Info

Pawan Chaudhary - Chairman Pawan Chaudhary - Managing Director

Registered Office

Address S. C. O. 857, C. No. 10,2nd Floor,N A C Manimajra,
Chandigarh,
Chandigarh-160101

Phone 0172-2561244/5577

Email info@venusremedies.com

Website www.venusremedies.com

Registrars Details

Link Intime India Pvt Ltd.

Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi

Listing : BSE, NSE, MCX

NEWS

06Mar Announcement under Regulation 30 (LOD
Venus Remedies takes its fight against AMR to next level, joins India AM..

06Mar Venus Remedies informs about press rel
Venus Remedies has informed that it enclosed a press release being issue..

27Feb Venus Remedies receives GMP certificat
Venus Remedies has received good manufacturing practices (GMP) certifica..

27Feb Venus Remedies gains on receiving GMP
Venus Remedies is currently trading at Rs. 162.85, up by 2.15 points or..

27Feb Venus Remedies informs about updates
Venus Remedies has informed that the company has awarded Saudi GMP appro..

Financials

in Millions

	QTR Dec 22	ANNUAL 22
Net Profit	26.1000000000001	489.86
Gross Profit	38.6000000000001	446.7
Operating Profit	108.3	772.5
Net Sales	1094.5	5751.81

EVENT CALENDAR

peer group

Abbott India (BSE) 21739.10 (0.69%)	M.Cap ( in Cr)46194.07
Neuland Laboratories (BSE) 1768.85 (4.17%)	M.Cap ( in Cr)2269.41
Pfizer (BSE) 3506.20 (1.83%)	M.Cap ( in Cr)16040.07
NGL Fine-Chem (BSE) 1240.10 (5.29%)	M.Cap ( in Cr)766.14
Alkem Laboratories (BSE) 3297.70 (1.64%)	M.Cap ( in Cr)39428.95

	NON-INSTITUTION	57.17%
	PROMOTERS	41.76%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Scheme Name	Hold(%)
Motilal Oswal S&P B...	0.02

About Venus Remedies Ltd.

Venus Remedies Ltd. was incorporated in the year 1989. Its today's share price is 164.15. Its current market capitalisation stands at Rs 219.42 Cr. In the latest quarter, company has reported Gross Sales of Rs. 5751.81 Cr and Total Income of Rs.5836.1 Cr. The company's management includes Neha Kodan, Savita Gupta, Navdeep Sud, Pravindra Singh Chauhan, S K Chadha, Gilbert Wenzel, Akshansh Chaudhary, Ashutosh Jain, Peeyush Jain, Manu Chaudhary, Pawan Chaudhary, Pawan Chaudhary.

It is listed on the BSE with a BSE Code of 526953 , NSE with an NSE Symbol of VENUSREM and ISIN of INE411B01019. It's Registered office is at S. C. O. 857, C. No. 10,2nd Floor,N A C ManimajraChandigarh-160101, Chandigarh. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are JK Jain & Associates, Prem Garg & Associates, Vinod Kumar & Associates

About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang Contact Dp Support Contact Trading Support

Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading

Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays T+1 Settlement securities

Derivatives Updates Market Report Overview

IPO IPO Issues Performance News & Analysis

Commodities Market Movers News & Commentary MCX / NCDEX Holidays MCX Data feed product and Charges

Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Mutual Fund Terms & Conditions Mutual Privacy Policy

Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research

Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap Do's And Dont'sInvestor Complaint Data

Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances NPS Grievance Policy SEBI Scores RMS Policy Inspection CSR Committee CSR Policy

CSR Activities

FY-2020-2021 FY-2021-2022 FY-2022-2023

Investor Charter

Linked content_Investor Charter for Depositories and DPs Investor Charter for Depositories and DPs Investor Charter for Stock Broker Investor Charter for Research Investor Complaints -RA Investor Complaints-NBEPL

Evoting

NSDL Evoting CDSL Evoting

Client Bank Account list

Connect with Us

ATTENTION INVESTORS Depository IPO KYC

Inactive account treatment NBSPL Policy of AML NBEPL Policy of AML NBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar Updation Nirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019

Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment INZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300

For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain. |

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Type	Charges (POA Clients)	Charges (Non-POA Clients)
Margin Pledge Creation/Initiation	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)
Margin Pledge Release	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)

Stock Price Quote